Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.

Pedro Póvoa,Jorge I. F. Salluh,Maria Martinez,Raquel Guillamat-Prats,Dianne Gallup,Hussein R. Al-Khalidi,B. Taylor Thompson,V. Marco Ranieri,Antonio Artigas

Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.

2015

Pedro Póvoa
Jorge I. F. Salluh
Maria Martinez
Raquel Guillamat-Prats
Dianne Gallup
Hussein R. Al-Khalidi
B. Taylor Thompson
V. Marco Ranieri
Antonio Artigas

Introduction The aim of our study was to evaluate the clinical impact of the administration of intravenous steroids, alone or in conjunction with drotrecogin-alfa (activated) (DrotAA), on the outcomes in septic shock patients.

Keywords:

Surviving Sepsis Campaign
Septic shock
Intensive care medicine
Randomized controlled trial
Intravenous steroids
Retrospective cohort study
Survival rate
Hydrocortisone
Medicine
Sepsis
Placebo
Propensity score matching

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations